Specification
Organism | Homo sapiens (Human) |
Expression Host | E.Coli |
Tag Info | Tag-Free |
Purity | >98% as determined by SDS-PAGE and HPLC. |
Uniprot ID | P81534 |
Uniprot Entry Name | D103A_HUMAN |
Gene Names | DEFB103A,BD3,DEFB103,DEFB3;,DEFB103B |
Alternative Names | Beta-defensin 3, DEFB-3, HBD3, hBD-3, Defensin, beta 103 |
Expression Region | Full Length of Mature Protein (23-67aa) |
Molecular Weight | 5.2 kDa |
Endotoxin | Less than 1.0 EU/µg as determined by LAL method. |
Sequence | GIINTLQKYY CRVRGGRCAV LSCLPKEEQI GKCSTRGRKC CRRKK |
Product Form | Lyophilized powder (Lyophilized from a 0.2 µm filtered 20 mM PB, pH 7.4, 130 mM NaCl) |
Reconstitution | Please reconstitute protein in deionized sterile water and we recommend that briefly centrifuge thevial prior to opening the vial .We recommend aliquot for long-term storage at -20℃/-80℃. |
Background
Relevance | Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed. {ECO:0000269|PubMed:11085990}. |
Function | Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed. |
Involvement in disease | |
Subcellular Location | Secreted |
Protein Families | Beta-defensin family |
Tissue Specificity | Highly expressed in skin and tonsils, and to a lesser extent in trachea, uterus, kidney, thymus, adenoid, pharynx and tongue. Low expression in salivary gland, bone marrow, colon, stomach, polyp and larynx. No expression in small intestine. |
Pathway |
QC Data
Note | Please contact us for QC Data |
Product Image (Reference Only) | ![]() |